Panacea Biotec Limited has sent reminder letters dated September 15, 2026, to shareholders holding shares in physical mode, requesting them to furnish PAN and KYC details for updation. This communication is made in compliance with SEBI Circular reference no. SEBI/HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 dated February 06, 2026, and SEBI Circular bearing reference no. SEBI/HO/MIRSD/MIRSD-POD-1/P/CIR/2024/81 dated June 10, 2024.

The mandatory requirements include updating PAN, address with PIN code, mobile number, bank account details, and specimen signatures. Email ID and nomination details are optional but encouraged.

Key consequences of non-compliance include:

  • Dividend/interest payments will be made only through electronic mode with effect from April 1, 2024, and only after furnishing all mandatory details
  • Physical shareholders cannot lodge grievances or avail any service requests from the Registrar & Transfer Agent (Skyline Financial Services Private Limited) until details are updated
  • Any dividends declared during the period from April 1, 2024, until KYC updation will be paid electronically only upon compliance

Shareholders are required to submit the following forms with self-attested copies of supporting documents:

  • Form ISR-1 for KYC details (PAN linked with Aadhar mandatory)
  • Form ISR-2 for signature mismatch cases (requires bank confirmation)
  • Form SH-13 for nomination details
  • Form ISR-3 for opting out of nomination
  • Form SH-14 for cancellation or variation in nomination

The forms are available on the company's website (https://www.panaceabiotec.com/en/investor-links/other-important-information) and RTA's website (https://www.skylinerta.com/pages/service-requests-kyc-forms.php).

The company strongly encourages physical shareholders to convert their holdings to dematerialized form as the company's securities are being traded only in dematerialized form. Shareholders may contact the RTA or company for assistance in dematerialization.

Contact information provided:

  • Panacea Biotec Limited: Corporate Office: B-1 Extn./A-27, Mohan Co-operative Industrial Estate, Mathura Road, New Delhi – 110044 | Email: companysec@panaceabiotec.com | Phone: +91-11-41679000 Extn. - 2073
  • Skyline Financial Services Private Limited: D-153A, 1st Floor, Okhla Industrial Area, Phase-I, New Delhi-110020 | Email: kyc@skylinerta.com | Phone: +91-11-40450193-97

This is the fifth communication sent to shareholders, following previous letters dated January 25, 2023, May 11, 2023, September 12, 2024, and September 19, 2025.